Minimally invasive surgery for deep brain bleeding
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain after a spontaneous bleed. It may help patients with moderate to large bleeds who are at least 18 and up to 80 years old.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You had a brain bleed in the basal ganglia area confirmed by a CT scan
- The bleed is between 30 and 80 mL in size
- You arrived at the hospital within 72 hours of the bleed starting
- Your level of consciousness at the hospital was between 5 and 14 on a scale called Glasgow Coma Scale
- You had no major disability before the bleed (mRS 0-1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a minimally invasive brain surgery using an endoscope can improve outcomes for people with a deep brain bleed. It also studies the safety of this approach compared with standard care.
This trial studies whether a minimally invasive, image-guided endoscopic procedure can remove blood after a specific type of brain bleed. It may help reduce symptoms and improve outcomes compared with standard care, but you must meet timing and medical criteria.
This trial tests a type of keyhole surgery called neuroendoscopic surgery to remove large blood clots in the brain. It may help people who have had a serious brain bleed and need urgent surgery.
This study tests a combination approach—using a scope through a small skull opening to remove the clot from a deep brain bleed (basal ganglia), then giving a steroid called methylprednisolone to reduce inflammation. It may help people with a moderate-sized bleed who get treated within 24 hours.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain caused by spontaneous bleeding. It aims to improve recovery for patients who meet specific criteria, such as clot size and time since symptoms started.
This trial studies whether a special scan-guided, minimally invasive procedure can safely remove bleeding in the basal ganglia (deep in the brain) soon after it happens. It may help patients recover better by targeting the bleeding while protecting important brain pathways.
Hear when a new Intracerebral Hemorrhage Basal Ganglia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.